Effectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02667366|
Recruitment Status : Recruiting
First Posted : January 28, 2016
Last Update Posted : October 25, 2016
|Condition or disease||Intervention/treatment||Phase|
|Depression||Behavioral: Tel-PT Behavioral: TAU and text messages||Not Applicable|
The overall purpose of the study is to examine the effectiveness of telephone psychotherapy (Tel-PT) for the treatment of mild to moderate depression on different outcome-levels and under clinically representative conditions in Swiss primary health care. The randomized-controlled trial (RCT) will evaluate the primary hypothesis that Tel-PT is more effective than routine primary care (i.e. treatment as usual, TAU), more specifically, that it leads to significant higher reduction in depression severity than TAU at follow-up.
The intervention group (IG) receives a manualized short-term cognitive behavioral treatment, which is the adapted German version of the program "Creating a balance" developed in the USA. The therapy consists of one face-to-face and 8-12 telephone contacts and is carried out by a licensed psychotherapist.
More concrete, recruitment and inclusion of the patients will be carried out by the participating general practitioners (GPs). GPs will be instructed to screen patients at risk for depression, especially those revealing diffuse somatic symptoms and suffering from chronic diseases. If positively screened, patient`s depressive symptoms are assessed with Patient Health Questionnaire (PHQ-9) and diagnosed according to ICD-10.
All GPs will receive an initial training prior to their participation, providing them with study information and procedures as well as training in screening procedure, psychodiagnostics and study enrolment.
Eligible patients are provided with detailed study information and asked to participate. Subsequently, patients will give informed consent. Patients will then be included into the study and fill out the baseline questionnaires (t0). After that, randomization will be carried out at the University of Zurich, based on an appropriately created computer algorithm. Both GPs and patients are informed about the results by the study team within two days. Subsequently, patients in control group (CG) will receive regular text messages and patients in the intervention group (IG) will be called by the study therapist to schedule an initial appointment.
In case of positive results, the overarching objective is the optimization of mental health services for depressed patients by implementing an evidence-based, accessible and cost-effective treatment option into primary care.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||216 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Improving Access to Evidence-based Treatment for Depression: Effectiveness and Cost-effectiveness of Telephone-delivered Cognitive Behavioral Therapy (CBT) in Primary Care|
|Study Start Date :||January 2016|
|Estimated Primary Completion Date :||January 2018|
|Estimated Study Completion Date :||January 2018|
Tel-PT receives a manualized short-term CBT. Treatment consists of one initial face-to-face appointment and 8-12 subsequent telephone sessions between patient and licensed therapist. Each telephone contact lasts between 20 and 30 minutes and take place on a weekly and later biweekly basis.
Active Comparator: TAU and text messages
Control Group receives treatment as usual and additionally weekly text messages containing general information about depression.
Behavioral: TAU and text messages
- Change in depressive symptoms [ Time Frame: t0 (baseline) and t2 (12 months after baseline) ]The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
- Change in depressive symptoms [ Time Frame: t0 (baseline) and t1 (four months after baseline) ]The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
- Response [ Time Frame: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline) ]Response defined as 50% reduction in the PHQ-9.
- Change in health-related quality of life [ Time Frame: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline) ]Change in health-related quality of life is measured with the 12-Item Short Form Health Survey (SF-12; Bullinger & Kirchberger, 1998).
- Self-efficacy for management and relapse prevention in depression [ Time Frame: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline) ]Depression self-efficacy scale for management and relapse prevention (Bush et al., 2001).
- Cost-effectiveness [ Time Frame: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline) ]Health care utilization and productivity loss will be measured with an adapted version of the Client Sociodemographic and Service Receipt Inventory (CSSRI; Chisholm et al., 2000). For Switzerland, country-specific unit costs will be employed to calculate direct and indirect costs.
- Cost-effectiveness [ Time Frame: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline) ]Health-related quality of life for the economic analyses will be measured using the EQ-5D-5L (The EuroQuol Group, 1990), Quality-adjusted life years (QALYs) based on the EQ-5D index will be determined and the incremental cost-effectiveness ratio (ICER) will be computed.
- Acceptance and satisfaction with the intervention [ Time Frame: t1 (four months after baseline) ]Patients' and therapists' acceptance and satisfaction with the intervention will be assessed by a self-constructed questionnaire.
- Process and structural variable [ Time Frame: t1 (four months after baseline), t2 (12 months after baseline) ]Mean duration of telephone contacts
- Process and structural variable [ Time Frame: t1 (four months after baseline), t2 (12 months after baseline) ]Mean number of telephone contacts.
- Process and structural variable [ Time Frame: t1 (four months after baseline), t2 (12 months after baseline) ]Dropout rate
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02667366
|Contact: Elisa Haller, MSc||004144 635 firstname.lastname@example.org|
|University of Zurich||Recruiting|
|Zurich, Switzerland, 8050|
|Contact: Elisa Haller, MSc +41 44 635 7335 email@example.com|
|Principal Investigator:||Birgit Watzke, Prof||University of Zurich, Department of Clinical Psychology and Psychotherapy Research|